“Cialis Challenge”: ED Drug Sampling Hides True Market Growth, Icos Says
Executive Summary
Increased prescription sampling within the erectile dysfunction market has caused an understatement of the category's overall growth, Icos VP-Sales & Marketing Leonard Blum told investors May 3
You may also be interested in...
King/Mylan Merger Will Provide Critical Mass To Develop Palatin ED Agent
Mylan's acquisition of King will provide the critical mass necessary to develop PT-141, a Phase II intranasal sexual dysfunction agent in-licensed from Palatin, King said
King/Mylan Merger Will Provide Critical Mass To Develop Palatin ED Agent
Mylan's acquisition of King will provide the critical mass necessary to develop PT-141, a Phase II intranasal sexual dysfunction agent in-licensed from Palatin, King said
Levitra Detailing Message Is “Rapid And Reliable”; Onset Of Action Studied
Bayer and GlaxoSmithKline are positioning Levitra as "rapid" and "reliable" in communications with doctors